Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100 | 110 | 210 | 10 | 60 |
| Receivables | 90 | 200 | 20 | 10 | 9 |
| Inventories | 620 | 630 | 700 | 990 | 990 |
| Other current assets | 210 | 170 | 370 | 400 | 431 |
| TOTAL | $1,020 | $1,110 | $1,300 | $1,410 | $1,490 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 545 | 130 | 140 | 145 | 155 |
| TOTAL | $545 | $130 | $140 | $145 | $155 |
| Total Assets | $1,700 | $1,590 | $1,810 | $1,910 | $2,010 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 290 | 250 | 260 | 120 | 180 |
| Accrued Expenses | 0 | 0 | 0 | 90 | 40 |
| TOTAL | $290 | $250 | $260 | $210 | $230 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,570 | 7,570 | 7,580 | 7,640 | 7,650 |
| Other Non-Current Liabilities | 1,080 | 970 | 850 | 730 | 600 |
| TOTAL | $8,650 | $8,540 | $8,430 | $8,370 | $8,250 |
| Total Liabilities | $8,950 | $8,800 | $8,700 | $8,590 | $8,490 |
| Shareholders' Equity | |||||
| Common Shares | 560 | 510 | 470 | 390 | 340 |
| Retained earnings | -29,010 | -28,450 | -28,000 | -27,200 | -26,710 |
| Other shareholders' equity | 420 | 420 | 420 | 460 | 450 |
| TOTAL | $-7,250 | $-7,210 | $-6,880 | $-6,670 | $-6,480 |
| Total Liabilities And Equity | $1,700 | $1,590 | $1,820 | $1,920 | $2,010 |